Login / Signup

Could menopause drug fezolinetant show promise for vasomotor symptoms associated with androgen deprivation therapy?

Kirby R QinEveline MertensJake A TempoMarlon PereraJanelle Brennan
Published in: Translational andrology and urology (2024)
Keyphrases
  • postmenopausal women
  • big data
  • adverse drug
  • machine learning
  • mesenchymal stem cells
  • artificial intelligence
  • cell therapy
  • bone marrow
  • electronic health record
  • smoking cessation